Harvoni is a lifesaving medication for people with hepatitis C. A four-week supply averaged $32,114 for privately
Question:
Harvoni is a lifesaving medication for people with hepatitis C. A four-week supply averaged $32,114 for privately insured patients in the United States in 2015. In Switzerland the price was $16,861. Why are the prices so different? Should the government intervene to reduce the price? How might the government intervene?
Fantastic news! We've Found the answer you've been seeking!
Step by Step Answer:
There are several reasons why the price of Harvoni is significantly different in the United States and Switzerland Some of the most significant factors include Drug development and research costs Phar...View the full answer
Answered By
Mugdha Sisodiya
My self Mugdha Sisodiya from Chhattisgarh India. I have completed my Bachelors degree in 2015 and My Master in Commerce degree in 2016. I am having expertise in Management, Cost and Finance Accounts. Further I have completed my Chartered Accountant and working as a Professional.
Since 2012 I am providing home tutions.
2+ Reviews
10+ Question Solved
Related Book For 
Question Posted:
